NASDAQ:LGVN Longeveron (LGVN) Stock Price, News & Analysis → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free LGVN Stock Alerts $3.25 +0.14 (+4.50%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$3.20▼$3.6450-Day Range$3.13▼$9.5052-Week Range$2.92▼$44.00Volume154,047 shsAverage Volume22,137 shsMarket Capitalization$8.16 millionP/E RatioN/ADividend YieldN/APrice Target$60.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Longeveron alerts: Email Address Longeveron MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,746.2% Upside$60.00 Price TargetShort InterestHealthy0.17% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 5 Articles This WeekInsider TradingAcquiring Shares$6,550 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.30 out of 5 stars 3.5 Analyst's Opinion Consensus RatingLongeveron has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $60.00, Longeveron has a forecasted upside of 1,746.2% from its current price of $3.25.Amount of Analyst CoverageLongeveron has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.17% of the float of Longeveron has been sold short.Short Interest Ratio / Days to CoverLongeveron has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Longeveron has recently decreased by 92.02%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldLongeveron does not currently pay a dividend.Dividend GrowthLongeveron does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LGVN. Previous Next 2.7 News and Social Media Coverage News SentimentLongeveron has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Longeveron this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for LGVN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Longeveron to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Longeveron insiders have bought more of their company's stock than they have sold. Specifically, they have bought $6,550.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders24.34% of the stock of Longeveron is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.01% of the stock of Longeveron is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Longeveron are expected to remain at ($8.50) per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of Longeveron is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Longeveron is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLongeveron has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Longeveron Stock (NASDAQ:LGVN)Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.Read More LGVN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LGVN Stock News HeadlinesMarch 23, 2024 | americanbankingnews.comLongeveron Stock Set to Reverse Split on Wednesday, March 27th (NASDAQ:LGVN)March 19, 2024 | globenewswire.comLongeveron Announces 1-for-10 Reverse Stock SplitMarch 29, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 1, 2024 | finance.yahoo.comLongeveron Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 29, 2024 | seekingalpha.comLongeveron Inc. (LGVN) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | investing.comLongeveron LLC earnings missed by $0.81, revenue topped estimatesFebruary 28, 2024 | finance.yahoo.comLongeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call TranscriptFebruary 27, 2024 | benzinga.comRecap: Longeveron Q4 EarningsMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 27, 2024 | globenewswire.comLongeveron Reports Year-End 2023 Results and Provides Corporate UpdateFebruary 22, 2024 | benzinga.comLongeveron Stock (NASDAQ:LGVN) Dividends: History, Yield and DatesFebruary 21, 2024 | finance.yahoo.comLongeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024February 21, 2024 | globenewswire.comLongeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024January 30, 2024 | markets.businessinsider.comBuy Rating Affirmed: Longeveron’s Intellectual Property and Pipeline Progress Signal Market GrowthJanuary 30, 2024 | theglobeandmail.comLongeveron (NASDAQ: LGVN) Granted US Patent Allowance for Key Tech Behind Lead Investigation ProductDecember 21, 2023 | marketwatch.comLongeveron Shares Hit 52-Week Low After Direct Offering PricesDecember 21, 2023 | msn.comWhy Longeveron (LGVN) Shares Are Falling SharplyDecember 21, 2023 | finance.yahoo.comUPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesDecember 21, 2023 | finance.yahoo.comLongeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesDecember 4, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of Longeveron Inc - (LGVN) with Buy RecommendationNovember 11, 2023 | benzinga.comLong-term Survival Data from Longeveron's ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart AssociationNovember 11, 2023 | finance.yahoo.comLongeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call TranscriptNovember 11, 2023 | finance.yahoo.comLong-term Survival Data from Longeveron’s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart AssociationNovember 10, 2023 | msn.comLGVN Continues to Show ProgressNovember 10, 2023 | finance.yahoo.comLongeveron Reports Third Quarter 2023 Results and Provides Corporate UpdateNovember 3, 2023 | finance.yahoo.comLongeveron to Report Third Quarter 2023 Results and Provide Corporate Update on November 10, 2023October 24, 2023 | finance.yahoo.comLongeveron Inc. Featured in Syndicated Broadcast Highlighting Top-Line Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ for the Treatment of Mild Alzheimer’sSee More Headlines Receive LGVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Longeveron and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today3/28/2024Next Earnings (Estimated)5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:LGVN CUSIPN/A CIK1721484 Webwww.longeveron.com Phone305-302-7158FaxN/AEmployees23Year FoundedN/APrice Target and Rating Average Stock Price Target$60.00 High Stock Price Target$60.00 Low Stock Price Target$60.00 Potential Upside/Downside+1,746.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,410,000.00 Net Margins-3,020.17% Pretax Margin-3,020.17% Return on Equity-209.14% Return on Assets-136.82% Debt Debt-to-Equity Ratio0.21 Current Ratio1.50 Quick Ratio1.50 Sales & Book Value Annual Sales$709,000.00 Price / Sales11.52 Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book12.04Miscellaneous Outstanding Shares2,513,000Free Float19,017,000Market Cap$8.17 million OptionableNot Optionable Beta0.32 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Joshua Michael Hare FACC (Age 61)M.D., Co-Founder, Chief Science Officer & Chairman Comp: $74kMr. Mohamed Wa'el Ahmed Hashad (Age 62)CEO & Director Comp: $781.56kMs. Lisa A. Locklear M.B.A. (Age 62)Executive VP & CFO Comp: $248.38kMr. Paul T. Lehr J.D. (Age 56)International Executive Director, General Counsel & Secretary Comp: $554.05kDr. Dan Gincel Ph.D. (Age 53)Senior Vice President of Strategic Collaborations & Scientific Affairs Dr. Nataliya Agafanova M.D. (Age 54)Chief Medical Officer Ms. Elly Ryu (Age 42)VP & Corporate Controller More ExecutivesKey CompetitorsClever LeavesNASDAQ:CLVRBionomicsNASDAQ:BNOXAlterity TherapeuticsNASDAQ:ATHECyclerion TherapeuticsNASDAQ:CYCNTonix PharmaceuticalsNASDAQ:TNXPView All CompetitorsInsiders & InstitutionsCitadel Advisors LLCBought 32,253 shares on 2/15/2024Ownership: 0.128%Armistice Capital LLCBought 1,836,000 shares on 2/13/2024Ownership: 7.312%Northern Trust CorpBought 39,130 shares on 2/13/2024Ownership: 0.198%Cathy RossBought 500 shares on 1/10/2024Total: $6,550.00 ($13.10/share)Jeffrey PfefferBought 1,000 shares on 12/28/2023Total: $13,500.00 ($13.50/share)View All Insider TransactionsView All Institutional Transactions LGVN Stock Analysis - Frequently Asked Questions Should I buy or sell Longeveron stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Longeveron in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LGVN shares. View LGVN analyst ratings or view top-rated stocks. What is Longeveron's stock price target for 2024? 1 Wall Street analysts have issued 12 month price objectives for Longeveron's stock. Their LGVN share price targets range from $60.00 to $60.00. On average, they anticipate the company's share price to reach $60.00 in the next year. This suggests a possible upside of 1,746.2% from the stock's current price. View analysts price targets for LGVN or view top-rated stocks among Wall Street analysts. How have LGVN shares performed in 2024? Longeveron's stock was trading at $13.60 on January 1st, 2024. Since then, LGVN stock has decreased by 76.1% and is now trading at $3.25. View the best growth stocks for 2024 here. Are investors shorting Longeveron? Longeveron saw a drop in short interest in March. As of March 15th, there was short interest totaling 15,400 shares, a drop of 92.0% from the February 29th total of 192,900 shares. Based on an average daily volume of 29,800 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.2% of the company's shares are short sold. View Longeveron's Short Interest. When is Longeveron's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our LGVN earnings forecast. How were Longeveron's earnings last quarter? Longeveron Inc. (NASDAQ:LGVN) released its earnings results on Tuesday, February, 27th. The company reported ($2.50) EPS for the quarter, missing analysts' consensus estimates of ($2.10) by $0.40. The company had revenue of $0.06 million for the quarter, compared to analysts' expectations of $0.21 million. Longeveron had a negative net margin of 3,020.17% and a negative trailing twelve-month return on equity of 209.14%. When did Longeveron's stock split? Shares of Longeveron reverse split on the morning of Wednesday, March 27th 2024. The 1-10 reverse split was announced on Wednesday, March 27th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 27th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did Longeveron IPO? Longeveron (LGVN) raised $30 million in an IPO on Friday, February 12th 2021. The company issued 2,700,000 shares at a price of $10.00-$12.00 per share. Kingswood Capital Markets and Alexander Capital L.P. acted as the underwriters for the IPO. Who are Longeveron's major shareholders? Longeveron's stock is owned by a number of institutional and retail investors. Top institutional investors include Armistice Capital LLC (7.31%), Northern Trust Corp (0.20%) and Citadel Advisors LLC (0.13%). Insiders that own company stock include Cathy Ross, Geoff Green, James Clavijo, Jeffrey Pfeffer, Joshua Hare, Paul T Lehr and Rock Soffer. View institutional ownership trends. How do I buy shares of Longeveron? Shares of LGVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:LGVN) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longeveron Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.